CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing Microneedle Array patches to deliver TNF-α inhibitors for treating mild to moderate psoriasis. By enhancing drug delivery through the skin, it aims to improve treatment efficacy while minimizing systemic side effects associated with traditional therapies.
Psoriasis, an autoimmune disorder characterized by keratinocyte hyperproliferation, predominantly manifests as plaque-type psoriasis, with a majority of cases being mild to moderate.
Current treatment approaches, such as topical therapy, often fall short due to limited skin permeability.
Systemic drugs and biologics, while effective, pose risks associated with high doses.
Addressing mild psoriasis presents the challenge of overcoming limited skin permeability and minimizing systemic drug toxicit…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Sweden, Stockholm
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
